The $14.5-billion investment in the Human Genome Project, completed a decade ago, has paid off more than 60-fold in new jobs, drugs and a rapidly expanding genetics industry, an analysis has found.
The endeavour to map human DNA in its entirety created $966 billion in economic impact, according to the study released by United for Medical Research and Battelle, two research advocacy groups.
Dozens of companies have started with the knowledge gained from the project, leading to new diagnostic tests and development of medicines that can be matched with gene variants linked to disease. The project triggered a new era in the life sciences, with new oncology drugs and screenings among the early developments in the field, said Greg Lucier, chief executive officer of Life Technologies.
-- Bloomberg News